Prof. Mohamad Mohty, MD, PhD / Christine N. Duncan, MD - Canceling the Cascade of VOD/SOS: Team-Based Prophylaxis, Diagnosis, and Customized Management

This content has been developed for healthcare professionals only.
Patients who seek health information should consult with their
physician or relevant patient advocacy groups.

For the full presentation, downloadable Practice Aids, slides,
and complete CME/NCPD information, and to apply for credit,
please visit us at PeerView.com/EJG865. CME/NCPD credit will be
available until March 20, 2025.


Canceling the Cascade of VOD/SOS: Team-Based Prophylaxis,
Diagnosis, and Customized Management


The Medical College of Wisconsin is accredited by the
Accreditation Council for Continuing Medical Education (ACCME) to
provide continuing medical education for physicians.


This activity was developed in collaboration with our educational
partner, PVI, PeerView Institute for Medical Education.


In support of improving patient care, PVI, PeerView Institute for
Medical Education, is jointly accredited by the Accreditation
Council for Continuing Medical Education (ACCME), the
Accreditation Council for Pharmacy Education (ACPE), and the
American Nurses Credentialing Center (ANCC), to provide
continuing education for the healthcare team.


SupportThis program is supported by an
independent medical education grant from Jazz Pharmaceuticals.


DisclosuresProf. Mohamad Mohty, MD, PhD,
has a financial interest/relationship or affiliation in the form
of:
Consultant and/or Advisor for Adaptive Biotechnologies; Amgen
Inc.; Astellas Pharma Inc.; Bristol Myers Squibb; GSK; Janssen
Pharmaceuticals, Inc.; Jazz Pharmaceuticals, Inc.; Novartis AG;
Pfizer; Sanofi; Stemline Therapeutics, Inc.; and Takeda
Pharmaceutical Company.
Honoraria from Adaptive Biotechnologies; Amgen Inc.; Astellas
Pharma Inc.; Bristol Myers Squibb; GSK; Janssen Pharmaceuticals,
Inc.; Jazz Pharmaceuticals, Inc.; Novartis AG; Pfizer; Sanofi;
Stemline Therapeutics, Inc.; and Takeda Pharmaceutical
Company.


Christine N. Duncan, MD, has a financial interest/relationship or
affiliation in the form of:
Consultant and/or Advisor for bluebird bio, Inc.; Jazz
Pharmaceuticals, Inc.; and Omeros Corporation.


Medical Director
Carmine DeLuca has no financial interests/relationships or
affiliations in relation to this activity.